首页> International journal of hematology> Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma: Case report and review of literature

Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma: Case report and review of literature

导出原文传递

翻译打印收藏纠错

第一作者： Muzaffar,J.

作者： Muzaffar,J. ^[1] ; Katragadda,L. ; Haider,S. ; Javed,A. ; Anaissie,E. ; Usmani,S.

作者单位： Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, 4301 West ^[1]

关键词 Acquired hemophilia Bleeding Factor VIII inhibitor Multiple myeloma

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

International journal of hematology

2012年95卷1期

102-106页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览2

点击下载本期目录封面

International journal of hematology

2012年95卷1期

102-106页

检索历史清除

Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma: Case report and review of literature

International journal of hematology

相似文献

同项目论文

International journal of hematology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma: Case report and review of literature

International journal of hematology

相似文献

同项目论文

International journal of hematology

相关期刊

检索历史清除